Published in Heart Vessels on July 31, 2010
Stenting of the right ventricular outflow tract in the high-risk infant with cyanotic teratology of Fallot. Pediatr Cardiol (2013) 0.86
Early versus delayed umbilical cord clamping in infants with congenital heart disease: a pilot, randomized, controlled trial. J Perinatol (2015) 0.80
Heterotaxy syndrome infants are at risk for early shunt failure after Ladd procedure. Ann Thorac Surg (2015) 0.78
Unilateral pulmonary artery banding to promote contralateral pulmonary artery growth. Heart Vessels (2012) 0.77
Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg (1981) 2.08
Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference? Circulation (2007) 1.64
Systemic pulmonary shunts in neonates: early clinical outcome and choice of surgical approach. Ann Thorac Surg (2000) 0.98
Two thousand Blalock-Taussig shunts: a six-decade experience. Ann Thorac Surg (2007) 0.98
Sternotomy approach for the modified Blalock-Taussig shunt. Circulation (1995) 0.92
Obstruction in modified Blalock shunts: a quantitative analysis with clinical correlation. Ann Thorac Surg (2005) 0.84
Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing shunt outcome. J Cardiovasc Surg (Torino) (1996) 0.83
Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth (2006) 0.81
Hybrid palliation in hypoplastic left heart syndrome. Curr Opin Cardiol (2007) 0.80
The modified Blalock-Taussig shunt: analysis of adequacy and duration of palliation. Circulation (1987) 0.78
Modified Blalock-Taussig shunt following long-term administration of prostaglandin E1 for ductus-dependent neonates with cyanotic congenital heart disease. J Thorac Cardiovasc Surg (1985) 0.77
International staging system for multiple myeloma. J Clin Oncol (2005) 11.29
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Aspirin for everyone older than 50? For. BMJ (2005) 3.02
Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard WHO protocol in Gambian mothers and infants: a randomised controlled trial. Lancet (2007) 3.01
Antimyeloma activity of heat shock protein-90 inhibition. Blood (2005) 2.24
Aspirin, salicylates, and cancer. Lancet (2009) 2.17
Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol (2011) 2.14
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood (2003) 2.11
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. J Clin Oncol (2005) 1.97
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J (2003) 1.81
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood (2011) 1.75
Effects of bone-targeted agents on cancer progression and mortality. J Natl Cancer Inst (2012) 1.69
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica (2014) 1.57
Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood (2008) 1.56
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol (2014) 1.52
Treatment of relapsed and refractory multiple myeloma in the era of novel agents. Cancer Treat Rev (2010) 1.48
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy. Cancer Cell Int (2005) 1.46
Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC Med (2008) 1.40
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype. Leuk Lymphoma (2008) 1.39
IMWG consensus on maintenance therapy in multiple myeloma. Blood (2012) 1.29
Essential role of proline isomerization in stefin B tetramer formation. J Mol Biol (2006) 1.23
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol (2013) 1.19
A national DNA bank in The Gambia, West Africa, and genomic research in developing countries. Nat Genet (2004) 1.13
Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod (2008) 1.13
Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr (2010) 1.04
Current multiple myeloma treatment strategies with novel agents: a European perspective. Oncologist (2010) 1.04
More patent protection for medicines with a new purpose. Nature (2010) 1.02
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma. Haematologica (2011) 1.01
Birth season and environmental influences on blood leucocyte and lymphocyte subpopulations in rural Gambian infants. BMC Immunol (2008) 1.01
Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer (2003) 1.01
Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv (2009) 0.96
Monsanto Technology LLC v. Cargill: a matter of construction. Nat Biotechnol (2008) 0.95
Phlebitis: treatment, care and prevention. Nurs Times (2011) 0.95
Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection. PLoS One (2011) 0.95
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia. J Clin Oncol (2010) 0.93
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Haematologica (2007) 0.92
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma. Leuk Lymphoma (2010) 0.91
High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum (2002) 0.90
A randomised trial of a remote home support programme for infants with major congenital heart disease. Heart (2012) 0.89
Efficacy and outcome of autologous transplantation in rare myelomas. Haematologica (2010) 0.89
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes. Haematologica (2012) 0.87
Lenalidomide: a new therapy for multiple myeloma. Cancer Treat Rev (2008) 0.86
Echocardiographic, chest X-ray and electrocardiogram findings in children presenting with heart failure to a Ugandan paediatric ward. Trop Doct (2007) 0.86
Multiple autophosphorylations significantly enhance the endoribonuclease activity of human inositol requiring enzyme 1α. BMC Biochem (2014) 0.85
Towards a safety net for management of 22q11.2 deletion syndrome: guidelines for our times. Eur J Pediatr (2014) 0.84
Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells. Blood (2002) 0.83
Pulmonary valve implantation using self-expanding tissue valve without cardiopulmonary bypass reduces operation time and blood product use. J Thorac Cardiovasc Surg (2012) 0.83
Using the Valeo dilatable stent in coarctation stenting for small children: expanding the inclusion criteria for coarctation stenting? BMJ Case Rep (2013) 0.83
Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy. Leuk Lymphoma (2012) 0.82
Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children. Catheter Cardiovasc Interv (2015) 0.82
Interactions of the auxilin-1 PTEN-like domain with model membranes result in nanoclustering of phosphatidyl inositol phosphates. Biophys J (2013) 0.81
Long-term effects of perinatal nutrition on T lymphocyte kinetics in young Gambian men. Am J Clin Nutr (2007) 0.81
Sympathetic ophthalmia secondary to cyclodiode laser in a 10-year-old boy. J AAPOS (2009) 0.81
Oestrogen receptor beta is present in both muscle fibres and endothelial cells within human skeletal muscle tissue. Histochem Cell Biol (2005) 0.80
Expression of prostaglandin E synthases in periodontitis immunolocalization and cellular regulation. Am J Pathol (2011) 0.80
Thymic stromal lymphopoietin is present in human breast milk. Pediatr Allergy Immunol (2010) 0.79
Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology. Br J Haematol (2002) 0.79
Updates to the guidelines for the diagnosis and management of multiple myeloma. Br J Haematol (2014) 0.79
Thymic function and T cell parameters in a natural human experimental model of seasonal infectious diseases and nutritional burden. J Biomed Sci (2011) 0.78
Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome. BMC Gastroenterol (2010) 0.78
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations. Br J Haematol (2011) 0.77
Innate and adaptive immune pathways to tolerance. Nestle Nutr Workshop Ser Pediatr Program (2009) 0.77
Patent foramen ovale closure with the Gore septal occluder: initial UK experience. Catheter Cardiovasc Interv (2013) 0.77
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma. Value Health (2011) 0.76
PFO closure in children. Catheter Cardiovasc Interv (2008) 0.76
What next for low dose aspirin? J Epidemiol Community Health (2005) 0.76
Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children. Catheter Cardiovasc Interv (2014) 0.76
The impact of cell culture equipment on energy loss. Lasers Med Sci (2013) 0.75
On the limitations of health impact assessment. Public Health (2009) 0.75
Aspirin resistance: What is the risk of cardiovascular morbidity? BMJ (2008) 0.75
Could vitamin S (salicylate) protect against childhood cancer? Med Hypotheses (2005) 0.75
Antibiotics and allergic disorders in childhood. Open Nurs J (2008) 0.75
CT or MRI for post-procedural aortic stenting? Heart (2011) 0.75
Aspirin for all over 50 revisited. Heart (2008) 0.75
High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases. Int Immunopharmacol (2002) 0.75
Designing and implementing healthy ageing policies. Perspect Public Health (2012) 0.75
Proprioception after total ankle arthroplasty. Foot Ankle Int (2008) 0.75
My health: whose responsibility? Low-dose aspirin and older people. Expert Rev Cardiovasc Ther (2006) 0.75
Wide-field Fizeau imaging telescope: experimental results. Appl Opt (2006) 0.75
Super-resolution reconstruction based on incoherent optical aperture synthesis. Opt Lett (2013) 0.75
The public health potential of aspirin. Pharmacol Toxicol (2002) 0.75
Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy. Hematology (2007) 0.75
Highlighting the importance of "popular epidemiology". J Epidemiol Community Health (2005) 0.75
Balloon debanding the pulmonary artery: in vitro studies and early clinical experience. Congenit Heart Dis (2009) 0.75
Reflective practice and self-awareness. Perspect Public Health (2009) 0.75
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors. Cancer Cell (2014) 0.75
Occlusion of modified Blalock-Taussig shunt after clopidogrel cessation. Ann Thorac Surg (2012) 0.75
The use of uncertainty analysis as a food waste estimation tool. Waste Manag Res (2009) 0.75
Vascular hemostasis bandage compared to standard manual compression after cardiac catheterization in children. Catheter Cardiovasc Interv (2011) 0.75
Life saving early and immediate aspirin: too little too late. Postgrad Med J (2008) 0.75
'Salicylic acid deficiency' has important public health implications. Eur J Public Health (2003) 0.75
Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre. Catheter Cardiovasc Interv (2009) 0.75
'Healthy ageing' agenda. Perspect Public Health (2012) 0.75
Precision of a novel computed tomographic method for quantification of femoral varus in dogs and an assessment of the effect of femoral malpositioning. Vet Surg (2013) 0.75
Retrieving a large embolised atrial septal occluder - hooked… and landed. Kardiol Pol (2017) 0.75
2020 vision for Welsh 'public health'? Proposing 'public sector' footprints. Perspect Public Health (2016) 0.75